1. Home
  2. TECH vs RKLB Comparison

TECH vs RKLB Comparison

Compare TECH & RKLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • RKLB
  • Stock Information
  • Founded
  • TECH 1976
  • RKLB 2006
  • Country
  • TECH United States
  • RKLB United States
  • Employees
  • TECH N/A
  • RKLB N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • RKLB Aerospace
  • Sector
  • TECH Health Care
  • RKLB Industrials
  • Exchange
  • TECH Nasdaq
  • RKLB Nasdaq
  • Market Cap
  • TECH 7.9B
  • RKLB 10.2B
  • IPO Year
  • TECH 1989
  • RKLB N/A
  • Fundamental
  • Price
  • TECH $49.94
  • RKLB $20.51
  • Analyst Decision
  • TECH Buy
  • RKLB Buy
  • Analyst Count
  • TECH 9
  • RKLB 13
  • Target Price
  • TECH $73.88
  • RKLB $24.05
  • AVG Volume (30 Days)
  • TECH 2.1M
  • RKLB 13.3M
  • Earning Date
  • TECH 05-07-2025
  • RKLB 05-08-2025
  • Dividend Yield
  • TECH 0.64%
  • RKLB N/A
  • EPS Growth
  • TECH N/A
  • RKLB N/A
  • EPS
  • TECH 0.83
  • RKLB N/A
  • Revenue
  • TECH $1,208,770,000.00
  • RKLB $466,016,000.00
  • Revenue This Year
  • TECH $8.19
  • RKLB $35.30
  • Revenue Next Year
  • TECH $8.61
  • RKLB $54.49
  • P/E Ratio
  • TECH $60.22
  • RKLB N/A
  • Revenue Growth
  • TECH 4.72
  • RKLB 64.98
  • 52 Week Low
  • TECH $46.44
  • RKLB $3.98
  • 52 Week High
  • TECH $85.57
  • RKLB $33.34
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.19
  • RKLB 47.31
  • Support Level
  • TECH $46.77
  • RKLB $21.50
  • Resistance Level
  • TECH $50.81
  • RKLB $23.20
  • Average True Range (ATR)
  • TECH 2.02
  • RKLB 1.20
  • MACD
  • TECH 0.41
  • RKLB 0.01
  • Stochastic Oscillator
  • TECH 46.82
  • RKLB 37.55

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About RKLB Rocket Lab USA Inc.

Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.

Share on Social Networks: